Sanofi Genzyme Includes Vulnerable Kiwis in Their Compassionate Access Program

by CAP | Feb 25, 2017 | Press Releases

Masterton, New Zealand – (February 25, 2017) – The New Zealand Pompe Network is ecstatic to announce that Sanofi Genzyme has offered Pompe disease patients in New Zealand access to their International Compassionate Access Program (ICAP) for the drug Myozyme®. A huge THANK YOU to Sanofi Genzyme for their generosity and their humanitarian program.